Predicting Treatment Discontinuation Among Patients with Multiple Sclerosis: Application of the Transtheoretical Model of Change-Reference-Cited by-同舟云学术

Predicting Treatment Discontinuation Among Patients with Multiple Sclerosis: Application of the Transtheoretical Model of Change

Published:2004-07 Issue:4 Volume:44 Page:445-454
ISSN:1544-3191
Container-title:Journal of the American Pharmacists Association
language:en
Short-container-title:Journal of the American Pharmacists Association

Author:

Berger Bruce A.,Hudmon Karen Suchanek,Liang Huigang

Publisher

Elsevier BV

Subject

Pharmacology,Pharmacy,Pharmacology (nursing)

Reference25 articles.

1. Multiple sclerosis: empirical literature for the clinical health psychologist;Mohr;J Clin Psychol.,2001

2. Biogen. MS Resource Center: Understanding MS. Accessed at: www.avonex.com/application/avonex?sess=O4SLtwywAneger9FqHX W2tMxEvwBlh2mzF7Rz17UDZjN1ZtCtMzL, August 23, 2001.

3. Biogen. [WWW Document]. Accessed at www.biogen.com/site/content/products/on_the_market.asp, August 23, 2001.

4. Depression as a major symptom of multiple sclerosis;Whitlock;J Neurol Neurosurg Psychiatry.,1980

5. Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment;Mohr;Multiple Sclerosis.,1996

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature Review;International Journal of MS Care;2023-09-01

2. Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network;Frontiers in Neurology;2021-03-17

3. Teaching motivational interviewing in a blended learning environment;Currents in Pharmacy Teaching and Learning;2020-06

4. The Use of Measurements and Health Behavioral Models to Improve Medication Adherence;Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries;2018

5. An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug;Patient Preference and Adherence;2016-12